Temat: "COVID-19 Vaccines"

Skocz do pozycji: 1 1.

Tytuł :: Covid-19 vaccines and variants of concern: A review.
Autorzy :: Hadj Hassine I; Unité de Recherche UR17ES30 'Génomique, Biotechnologie et Stratégies Antivirales', Institut Supérieur de Biotechnologie, Université de Monastir, Monastir, Tunisia.; Pokaż więcej
Źródło :: Reviews in medical virology [Rev Med Virol] 2022 Jul; Vol. 32 (4), pp. e2313. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji :: Journal Article; Review
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/therapeutic use
Antibodies, Viral ; BNT162 Vaccine ; ChAdOx1 nCoV-19 ; Humans ; SARS-CoV-2/genetics ; Spike Glycoprotein, Coronavirus ; Vaccines, Synthetic
SCR Organism :: SARS-CoV-2 variants
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: [Vaccines against coronavirus disease 2019 (COVID-19) : Efficacy comparison, safety aspects, and current challenges].
Autorzy :: Lipp HP; Universitätsapotheke, Universitätsklinikum Tübingen, Otfried-Müller-Straße 4, 72076, Tübingen, Deutschland. .; Pokaż więcej
Transliterated Title :: Impfstoffe gegen „coronavirus disease 2019“ (COVID-19) : Wirksamkeitsvergleich, Sicherheitsaspekte und aktuelle Herausforderungen.
Źródło :: Innere medizin (Heidelberg, Germany) [Inn Med (Heidelb)] 2022 Jun; Vol. 63 (6), pp. 666-679. Date of Electronic Publication: 2022 May 11.
Typ publikacji :: Journal Article; Review
MeSH Terms :: COVID-19*
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Antibodies, Viral ; Child ; Female ; Humans ; Immunocompromised Host ; Myocarditis/chemically induced ; Pandemics/prevention & control ; Pregnancy ; Spike Glycoprotein, Coronavirus ; Thrombocytopenia/chemically induced
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.
Autorzy :: Zhang Y; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Lu M; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Mahesh KC; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Kim E; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Shamseldin MM; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Ye C; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227.
Dravid P; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Chamblee M; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Park JG; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227.
Hall JM; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Trivedi S; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Chaiwatpongsakorn S; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Kenny AD; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Murthy SS; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Sharma H; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.
Liang X; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.
Yount JS; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Kapoor A; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.
Martinez-Sobrido L; Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227.
Dubey P; Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Boyaka PN; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.
Peeples ME; Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH 43205.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.; Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, OH 43210.
Li J; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH 43210.; Infectious Disease Institute, The Ohio State University, Columbus, OH 43210.; Pokaż więcej
Źródło :: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Aug 16; Vol. 119 (33), pp. e2201616119. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/genetics
COVID-19 Vaccines*/immunology
Measles-Mumps-Rubella Vaccine*/genetics
Measles-Mumps-Rubella Vaccine*/immunology
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
Spike Glycoprotein, Coronavirus*/genetics
Spike Glycoprotein, Coronavirus*/immunology
Vaccine Efficacy*
Animals ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Immunogenicity, Vaccine ; Mesocricetus ; Mice ; Mumps virus/genetics ; Mumps virus/immunology ; Proline/genetics ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/immunology
SCR Organism :: SARS-CoV-2 variants
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Communicating about COVID-19 vaccine development and safety.
Autorzy :: Thorpe A; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
Fagerlin A; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
Butler J; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.; Geriatrics Research, Education, and Clinical Center (GRECC), VA Salt Lake City Health Care System, Salt Lake City, UT, United States of America.
Stevens V; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
Drews FA; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.; University of Utah College of Social and Behavioral Science, Salt Lake City, UT, United States of America.
Shoemaker H; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.; Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation, Salt Lake City, UT, United States of America.
Riddoch MS; Spencer Fox Eccles School of Medicine at University of Utah, Salt Lake City, UT, United States of America.
Scherer LD; University of Colorado School of Medicine, Aurora, CO, United States of America.; VA Denver Center for Innovation, Denver, CO, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2022 Aug 05; Vol. 17 (8), pp. e0272426. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
Health Communication*
Vaccine Development*
Health Knowledge, Attitudes, Practice ; Humans ; Intention ; Vaccination/psychology ; Vaccination Hesitancy ; Vaccines
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 5 5.

Tytuł :: Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children.
Autorzy :: Mariani M; Infectious Diseases Unit and COVID Hospital, IRCCS Istituto Giannina Gaslini, Genoa, Italy. .; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genoa, Italy. .
Caorsi R; Clinic of Paediatrics and Rheumatology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Consolaro A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genoa, Italy.; Clinic of Paediatrics and Rheumatology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Brisca G; Subintensive Care Unit COVID-19, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Sticchi C; Regional Health Agency of Liguria (ALiSa), Genoa, Italy.
Gattorno M; Clinic of Paediatrics and Rheumatology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Castagnola E; Infectious Diseases Unit and COVID Hospital, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Ravelli A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Genoa, Italy.; Scientific Directory, IRCCS Istituto Giannina Gaslini, Genoa, Italy.; Pokaż więcej
Źródło :: Italian journal of pediatrics [Ital J Pediatr] 2022 Aug 04; Vol. 48 (1), pp. 142. Date of Electronic Publication: 2022 Aug 04.
Typ publikacji :: Letter
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/therapeutic use
Myocarditis*/chemically induced
Systemic Inflammatory Response Syndrome*/prevention & control
Child ; Humans ; Italy ; SARS-CoV-2 ; Vaccination/adverse effects
SCR Disease Name :: pediatric multisystem inflammatory disease, COVID-19 related
: Opinia redakcyjna

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.
Autorzy :: Townsend JP; Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06525.; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511.; Program in Microbiology, Yale University, New Haven, CT 06511.
Hassler HB; Department of Biostatistics, Yale School of Public Health, New Haven, CT 06510.
Sah P; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06525.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520.
Galvani AP; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06525.; Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT 06525.; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06520.
Dornburg A; Department of Bioinformatics and Genomics, University of North Carolina, Charlotte, NC 28223.; Pokaż więcej
Źródło :: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Aug 02; Vol. 119 (31), pp. e2204336119. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji :: Comparative Study; Journal Article
MeSH Terms :: COVID-19*/immunology
COVID-19*/prevention & control
COVID-19*/virology
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/therapeutic use
Immunogenicity, Vaccine*
SARS-CoV-2*/immunology
Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antibody Formation ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Spike Glycoprotein, Coronavirus/immunology ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Attitude and Acceptance of COVID-19 Vaccine in Parents and Adolescents: A Nationwide Survey.
Autorzy :: Lee H; Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea; Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
Choe YJ; Department of Pediatrics, Korea University Anam Hospital, Seoul, Korea.
Kim S; Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Korea.
Cho HK; Department of Pediatrics, Gachon University College of Medicine, Gil Medical Center, Incheon, Korea.
Choi EH; Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea; Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
Lee J; Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea.
Bae H; Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea.
Choi SR; Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea.
You M; Department of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Korea. Electronic address: .; Pokaż więcej
Źródło :: The Journal of adolescent health : official publication of the Society for Adolescent Medicine [J Adolesc Health] 2022 Aug; Vol. 71 (2), pp. 164-171. Date of Electronic Publication: 2022 Jun 16.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*
Adolescent ; Child ; Humans ; Parents/education ; Surveys and Questionnaires ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 - 21 years old: A Systematic Review and Meta-analysis.
Autorzy :: Sadeghi S; Department of Pediatrics, Division of Dermatology, University of Calgary, Alberta Children's Hospital, Calgary, AB, Canada; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: .
Kalantari Y; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: .
Shokri S; Department of Pediatrics, Allergy and Clinical Immunology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: .
Fallahpour M; Department of Pediatrics, Allergy and Clinical Immunology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: .
Nafissi N; Department of General Surgery, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: .
Goodarzi A; Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Iran Jordan Dermatology and Hair Transplantation Center, Tehran, Iran. Electronic address: Azadeh_.
Valizadeh R; Department of Epidemiology, Student Research Committee, School of Public Health, Iran University of Medical science, Tehran, Iran and Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran. Electronic address: .; Pokaż więcej
Źródło :: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2022 Aug; Vol. 153, pp. 105196. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/therapeutic use
Ad26COVS1 ; Adolescent ; BNT162 Vaccine ; Child ; Child, Preschool ; Humans ; Myocarditis/chemically induced ; Pandemics/prevention & control ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplant.
Autorzy :: Murray SM; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Barbanti M; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Campbell C; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
Brown A; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Chen L; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Dhanapal J; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Tseu B; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Pervaiz O; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Peters L; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Springett S; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Danby R; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Adele S; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Phillips E; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Malone T; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Amini A; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford Liver Unit, Translational Gastroenterology Unit, Experimental Medicine Division Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Stafford L; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Deeks AS; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Dunachie S; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Oxford Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Klenerman P; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Peniket A; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Barnes E; Peter Medawar Building for Pathogen Research Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford Liver Unit, Translational Gastroenterology Unit, Experimental Medicine Division Oxford University Hospitals NHS Foundation Trust, University of Oxford, Oxford, UK.
Kesavan M; Department of Haematology, NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, UK.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (4), pp. 668-679. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*/prevention & control
COVID-19*/virology
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
COVID-19 Vaccines*/pharmacology
COVID-19 Vaccines*/therapeutic use
Hematopoietic Stem Cell Transplantation*/adverse effects
Age Factors ; Antibodies, Viral/immunology ; BNT162 Vaccine/immunology ; BNT162 Vaccine/therapeutic use ; Bone Marrow Transplantation/adverse effects ; ChAdOx1 nCoV-19/immunology ; ChAdOx1 nCoV-19/therapeutic use ; Humans ; Immunity, Cellular/drug effects ; Immunity, Cellular/immunology ; Immunity, Humoral/drug effects ; Immunity, Humoral/immunology ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Seroconversion ; Transplantation, Homologous/adverse effects ; Vaccination/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: COVID-19 vaccines in pregnancy.
Autorzy :: Nunes MC; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Madhi SA; South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: .; Pokaż więcej
Źródło :: Trends in molecular medicine [Trends Mol Med] 2022 Aug; Vol. 28 (8), pp. 662-680. Date of Electronic Publication: 2022 May 03.
Typ publikacji :: Journal Article; Review
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Pregnancy Complications, Infectious*/prevention & control
Female ; Humans ; Immunogenicity, Vaccine ; Infant, Newborn ; Pregnancy ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Response to Third Dose of Vaccine Against SARS-CoV-2 in Adolescent and Young Adult Kidney Transplant Recipients.
Autorzy :: Cirillo L; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio,' University of Florence, Florence, Italy.; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, Italy.
Citera F; Section of Pediatrics, Department of Health Sciences, Meyer Children's University Hospital, Florence, Italy.
Mazzierli T; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio,' University of Florence, Florence, Italy.
Becherucci F; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, Italy.
Terlizzi V; Cystic Fibrosis Regional Reference Center, Department of Pediatric Medicine, Meyer Children's University Hospital, Florence, Italy.
Lodi L; Section of Pediatrics, Department of Health Sciences, Meyer Children's University Hospital, Florence, Italy.
Buti E; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, Italy.
Romagnani P; Department of Biomedical, Experimental and Clinical Sciences 'Mario Serio,' University of Florence, Florence, Italy.; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence, Italy.; Pokaż więcej
Źródło :: Transplantation [Transplantation] 2022 Aug 01; Vol. 106 (8), pp. e386-e387. Date of Electronic Publication: 2022 May 18.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
Kidney Transplantation*
Transplant Recipients*
Adolescent ; COVID-19/prevention & control ; Humans ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.
Autorzy :: Giannoccaro MP; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy. .; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy. .
Vacchiano V; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.
Leone M; Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Section of Microbiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Camilli F; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Zenesini C; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.
Panzera I; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.
Balboni A; Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Section of Microbiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Tappatà M; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.
Borghi A; IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurology and Metropolitan Stroke Center, 'C.A. Pizzardi' Maggiore Hospital, Bologna, Italy.
Salvi F; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.
Lugaresi A; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.
Rinaldi R; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Interaziendale Metropolitana (NeuroMet), - Neurologia AOU S.Orsola-Malpighi, Bologna, Italy.
Di Felice G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Occupational Health Unit, Istituto di Ricovero e Cura a Carattere Scientifico St. Orsola Polyclinic, University of Bologna, Bologna, Italy.
Lodi V; Occupational Health Unit, Istituto di Ricovero e Cura a Carattere Scientifico St. Orsola Polyclinic, University of Bologna, Bologna, Italy.
Lazzarotto T; Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Section of Microbiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Liguori R; Dipartimento di Scienze Biomediche e Neuromotorie, Università di Bologna, Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, Via Altura 3, 40139, Bologna, Italy.; Pokaż więcej
Corporate Authors :: ANCOVAX study group
Źródło :: Journal of neurology [J Neurol] 2022 Aug; Vol. 269 (8), pp. 4000-4012. Date of Electronic Publication: 2022 May 03.
Typ publikacji :: Journal Article
MeSH Terms :: Autoimmune Diseases of the Nervous System*
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Immunity, Humoral*
2019-nCoV Vaccine mRNA-1273 ; Adult ; Aged ; Antibodies, Viral ; BNT162 Vaccine ; Fingolimod Hydrochloride ; Humans ; Immunoglobulin G ; Longitudinal Studies ; Middle Aged ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
Autorzy :: Hall VG; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Al-Alahmadi G; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Solera JT; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Marinelli T; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.; Department of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Cardinal H; Department of Medicine, University of Montreal, Montreal, QC, Canada.
Prasad GVR; Kidney Transplant Program, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
De Serres SA; Transplantation Unit, Renal Division, Department of Medicine, University Health Center of Quebec, Faculty of Medicine, Laval University, Québec, QC, Canada.
Isaac D; Division of Transplant Medicine, University of Calgary, Calgary, AB, Canada.
Mainra R; Saskatchewan Transplant Program, Transplantation Unit, Renal Division, Department of Medicine, University Health Center of Saskatchewan, Saskatoon, SK, Canada.
Lamarche C; Hôpital Maisonneuve-Rosemont Research Institute, Université de Montréal, Montréal, QC, Canada.
Sapir-Pichhadze R; Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, QC, Canada.; Division of Nephrology, Department of Medicine, McGill University, Montreal, QC, Canada.; Department of Epidemiology, Biostatistics, Occupational Health, McGill University, Montreal, QC, Canada.
Gilmour S; Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.
Matelski J; Biostatistics Research Unit, University Health Network, Toronto, ON, Canada.
Humar A; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Kumar D; Transplant Infectious Diseases and Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.; Pokaż więcej
Źródło :: Transplantation [Transplantation] 2022 Aug 01; Vol. 106 (8), pp. 1622-1628. Date of Electronic Publication: 2022 May 03.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
Transplant Recipients*
Cohort Studies ; Humans ; Organ Transplantation ; Vaccination/statistics & numerical data
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: COVID-19 vaccination during pregnancy: coverage and safety, a comment.
Autorzy :: Davies D; Department of Obstetrics and Gynaecology, North Middlesex University Hospital, London, United Kingdom.
McDougall A; Department of Obstetrics and Gynaecology, North Middlesex University Hospital, London, United Kingdom.
Yoong W; Department of Obstetrics and Gynaecology, North Middlesex University Hospital, London, United Kingdom. Electronic address: .; Pokaż więcej
Źródło :: American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2022 Aug; Vol. 227 (2), pp. 370. Date of Electronic Publication: 2022 Apr 22.
Typ publikacji :: Letter; Comment
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
Female ; Humans ; Pregnancy ; Vaccination
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Overview of Reported Breast Implant-Related Reactions After COVID-19 Infection or Vaccination.
Autorzy :: Mahrhofer M; Department of Plastic and Reconstructive Surgery, Marienhospital Stuttgart, Stuttgart, Germany.
Weitgasser L; Department of Plastic and Reconstructive Surgery, Marienhospital Stuttgart, Stuttgart, Germany.
Schoeller T; Department of Plastic and Reconstructive Surgery, Marienhospital Stuttgart, Stuttgart, Germany.; Pokaż więcej
Źródło :: Aesthetic surgery journal [Aesthet Surg J] 2022 Aug 01; Vol. 42 (8), pp. NP569-NP570.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Breast Implantation*/adverse effects
Breast Implants*/adverse effects
COVID-19*/epidemiology
COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/adverse effects
Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice.
Autorzy :: Lin K; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Liu M; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Bao L; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Lv Q; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Zhu H; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Li D; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Xu Y; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Xiang Z; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Liu J; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Liang X; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Han Y; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Cong Z; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Liu R; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Deng R; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Wang S; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Guo Z; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Sun L; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Wei Q; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Qiao H; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Wang S; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Pan S; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China.
Gao H; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China. Electronic address: .
Qin C; Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021, China. Electronic address: .; Pokaż więcej
Źródło :: Vaccine [Vaccine] 2022 Jul 30; Vol. 40 (32), pp. 4609-4616. Date of Electronic Publication: 2022 Jun 08.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Lactation*
Angiotensin-Converting Enzyme 2 ; Animals ; Female ; Humans ; Mice ; Mice, Transgenic ; Pregnancy ; SARS-CoV-2 ; Vaccines, Inactivated
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Autorzy :: Walker JL; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; NIHR Health Protection Research Unit (HPRU) in Vaccines and Immunisation; UK Health Security Agency, 61 Colindale Ave, London NW9 5EQ, UK.
Schultze A; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Tazare J; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Tamborska A; NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Science, University of Liverpool, UK; Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK.
Singh B; NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Science, University of Liverpool, UK; Tropical and Infectious Diseases Unit, Royal Liverpool University Hospital, Liverpool L7 8XP, UK.
Donegan K; Medicines and Healthcare products Regulatory Agency (MHRA), 10 South Colonnade, Canary Wharf, London E14 4PU, UK.
Stowe J; UK Health Security Agency, 61 Colindale Ave, London NW9 5EQ, UK.
Morton CE; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Hulme WJ; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Curtis HJ; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Williamson EJ; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Mehrkar A; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Eggo RM; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Rentsch CT; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Mathur R; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Bacon S; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Walker AJ; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Davy S; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Evans D; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Inglesby P; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Hickman G; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
MacKenna B; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Tomlinson L; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Ca Green A; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Fisher L; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Cockburn J; OpenSAFELY Collaborative, UK; TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.
Parry J; OpenSAFELY Collaborative, UK; TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.
Hester F; OpenSAFELY Collaborative, UK; TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.
Harper S; OpenSAFELY Collaborative, UK; TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.
Bates C; OpenSAFELY Collaborative, UK; TPP, TPP House, 129 Low Lane, Horsforth, Leeds LS18 5PX, UK.
Evans SJ; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Solomon T; NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Science, University of Liverpool, UK; Department of Neurology, Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, UK.
Andrews NJ; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; NIHR Health Protection Research Unit (HPRU) in Vaccines and Immunisation; UK Health Security Agency, 61 Colindale Ave, London NW9 5EQ, UK.
Douglas IJ; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Goldacre B; OpenSAFELY Collaborative, UK; The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX26GG, UK.
Smeeth L; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; NIHR Health Protection Research Unit (HPRU) in Vaccines and Immunisation.
McDonald HI; OpenSAFELY Collaborative, UK; London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK; NIHR Health Protection Research Unit (HPRU) in Vaccines and Immunisation. Electronic address: .; Pokaż więcej
Źródło :: Vaccine [Vaccine] 2022 Jul 30; Vol. 40 (32), pp. 4479-4487. Date of Electronic Publication: 2022 Jun 07.
Typ publikacji :: Journal Article
MeSH Terms :: Bell Palsy*/chemically induced
Bell Palsy*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
Facial Paralysis*/chemically induced
Facial Paralysis*/epidemiology
Guillain-Barre Syndrome*/chemically induced
Guillain-Barre Syndrome*/epidemiology
Myelitis, Transverse*/complications
2019-nCoV Vaccine mRNA-1273 ; BNT162 Vaccine ; ChAdOx1 nCoV-19 ; England ; Humans ; Vaccination/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Autorzy :: Ab Rahman N; Institute for Clinical Research, National Institutes of Health, Selangor, Malaysia. Electronic address: .
Lim MT; Institute for Clinical Research, National Institutes of Health, Selangor, Malaysia.
Lee FY; Institute for Clinical Research, National Institutes of Health, Selangor, Malaysia.
Lee SC; National Pharmaceutical Regulatory Agency, Selangor, Malaysia.
Ramli A; National Pharmaceutical Regulatory Agency, Selangor, Malaysia.
Saharudin SN; Clinical Research Centre, Shah Alam Hospital, Selangor, Malaysia.
King TL; Clinical Research Centre, Sarawak General Hospital, Sarawak, Malaysia.
Anak Jam EB; Clinical Research Centre, Queen Elizabeth II Hospital, Sabah, Malaysia.
Ayub NA; Clinical Research Centre, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.
Sevalingam RK; Clinical Research Centre, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.
Bahari R; Clinical Research Centre, Putrajaya Hospital, Putrajaya, Malaysia.
Ibrahim NN; Clinical Research Centre, Putrajaya Hospital, Putrajaya, Malaysia.
Mahmud F; Clinical Research Centre, Tengku Ampuan Afzan Hospital, Pahang, Malaysia.
Sivasampu S; Institute for Clinical Research, National Institutes of Health, Selangor, Malaysia.
Peariasamy KM; Institute for Clinical Research, National Institutes of Health, Selangor, Malaysia.; Pokaż więcej
Corporate Authors :: SAFECOVAC study group
Źródło :: Vaccine [Vaccine] 2022 Jul 30; Vol. 40 (32), pp. 4394-4402. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19 Vaccines*/adverse effects
BNT162 Vaccine ; Bell Palsy/chemically induced ; Bell Palsy/epidemiology ; ChAdOx1 nCoV-19 ; Humans ; Malaysia/epidemiology ; Myocardial Infarction/chemically induced ; Myocardial Infarction/epidemiology ; Myocarditis/chemically induced ; Myocarditis/epidemiology ; Pericarditis/chemically induced ; Pericarditis/epidemiology ; Seizures/chemically induced ; Stroke/chemically induced ; Stroke/epidemiology ; Thrombocytopenia/chemically induced ; Thrombocytopenia/epidemiology ; Vaccines, Inactivated ; Venous Thromboembolism/chemically induced ; Venous Thromboembolism/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS.
Autorzy :: Stevens KI; Glasgow Renal and Transplant Unit, Queen Elizabeth University Hospital, Glasgow, UK.
Frangou E; Department of Nephrology, Limassol General Hospital, Limassol, Cyprus.
Shin JIL; Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea.
Anders HJ; Division of Nephrology, Department of Internal Medicine IV, Ludwig-Maximilians-University Hospital, Munich, Germany.
Bruchfeld A; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.; Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden.
Schönermarck U; Division of Nephrology, Department of Internal Medicine IV, Ludwig-Maximilians-University Hospital, Munich, Germany.
Hauser T; IZZ Immunologie-Zentrum Zürich, Zurich, Switzerland.
Westman K; Division of Nephrology, Department of Clinical Sciences Lund, Lund University and Skane University Hospital, Lund, Sweden.
Fernandez-Juarez GM; Department of Nephrology, Hospital Universitatio Fundacion Alcorcon, Alcorcon, Spain.
Floege J; Division of Nephrology, RWTH Aachen University Hospital, Aachen, Germany.
Goumenos D; Department of Nephrology and Renal Transplantation, Patras University Hospital, Patras, Greece.
Turkmen K; Division of Nephrology, Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey.
van Kooten C; Division of Nephrology and Transplant Medicine, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
McAdoo SP; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.; Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
Tesar V; Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Segelmark M; Division of Nephrology, Department of Clinical Sciences Lund, Lund University and Skane University Hospital, Lund, Sweden.
Geetha D; Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jayne DRW; Department of Medicine, University of Cambridge, Cambridge, UK.
Kronbichler A; Department of Medicine, University of Cambridge, Cambridge, UK.; Pokaż więcej
Corporate Authors :: Immunonephrology Working Group (IWG) of the European Renal Association (ERA) and the European Vasculitis Society (EUVAS)
Źródło :: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2022 Jul 26; Vol. 37 (8), pp. 1400-1410.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19 Vaccines*/adverse effects
COVID-19 Vaccines*/immunology
Kidney Diseases*/drug therapy
Kidney Diseases*/immunology
Antibodies, Viral ; COVID-19/prevention & control ; Humans ; Mycophenolic Acid/therapeutic use ; Rituximab/therapeutic use
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Perception of COVID-19 Booster Dose Vaccine among Healthcare Workers in India and Saudi Arabia.
Autorzy :: Vellappally S; Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.; Dental Biomaterials Research Chair, Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Naik S; Dental Biomaterials Research Chair, Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Alsadon O; Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Al-Kheraif AA; Dental Biomaterials Research Chair, Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Alayadi H; Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Alsiwat AJ; Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Kumar A; Department of Prosthodontics, Amritha School of Dentistry, Vishwavidyapeetham, Cochin 682041, KL, India.
Hashem M; Dental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia.
Varghese N; MACFAST, Tiruvalla 689101, KL, India.
Thomas NG; Department of Periodontology, Pushpagiri College of Dental Sciences, Thiruvalla 689107, KL, India.
Anil S; Department of Dentistry, Oral Health Institute, Hamad Medical Cooperation, Doha 3050, Qatar.; College of Dental Medicine, Qatar University, Doha 2713, Qatar.; Pokaż więcej
Źródło :: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Jul 22; Vol. 19 (15). Date of Electronic Publication: 2022 Jul 22.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*/prevention & control
COVID-19 Vaccines*
Cross-Sectional Studies ; Health Personnel ; Humans ; Male ; Perception ; Saudi Arabia
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaBiblioteka WSB w Toruniu

Wyszukujesz frazę ""COVID-19 Vaccines"" wg kryterium: Temat

Źródło danych

Dostawca treści

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Hasło geograficzne

Kolekcja